Latest News:

NextSource Materials Secures Partnership with Major Electric Vehicle Supply Chain to Build Battery Anode Facility (NSRCF)
St-Georges Releases Initial Cathode Material EV Battery Test Results (SXOOF)
NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission (GNBT)
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment (HALB)
PlantX Announces Monthly Gross Revenues of $1,565,982 for March 2021 and $1,353,613 for February 2021 (PLTXF)

Stock Day Media

Ticker Tape by TradingView

News
Radio Show
- Be on our Show!
- Video Interviews
Technology
Cannabis
Energy
BioTech
Mining
Contact Us
- About Us
- Suggestion Box

Subscribe to the latest in penny stock micro-cap news and stock podcasts, straight to your inbox.
Subscribe Now

SILO

Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology (SILO)

April 7, 2021April 7, 2021 Stock Day Media 101 Views SILO, silopharma, therapeutics, Treatment

Agreement to explore the use of Silo Pharma’s Novel Peptide Englewood Cliffs, NJ, April 07, 2021 (GLOBE NEWSWIRE) — Silo

Read more

Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

January 13, 2021January 13, 2021 Stock Day Media 169 Views Baltimore, centralnervoussystem, Maryland, multiplescelrosis, psilocybin, SILO, silopharmainc

Silo Pharma could Utilize Data for Psilocybin Delivery potential to Central Nervous System Englewood Cliffs, NJ, Jan. 13, 2021 (GLOBE

Read more

Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

January 11, 2021January 11, 2021 Stock Day Media 169 Views cancer, cancerapplications, patentlicense, psilocybin, SILO, silopharma

Englewood Cliffs, NJ, Jan. 11, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

Read more

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

January 6, 2021January 6, 2021 Stock Day Media 250 Views applications, Pharma, psilocybincancer, SILO, silopharmainc, therapeutic

Englewood Cliffs, NJ, Jan. 06, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on

Read more

Latest News

NextSource Materials Secures Partnership with Major Electric Vehicle Supply Chain to Build Battery Anode Facility (NSRCF)

April 12, 2021 Stock Day Media Comments Off on NextSource Materials Secures Partnership with Major Electric Vehicle Supply Chain to Build Battery Anode Facility (NSRCF)

NEWS RELEASE – TORONTO, April 12, 2021 • Three-way partnership pairs NextSource with a leading processor and a supplier of

St-Georges Releases Initial Cathode Material EV Battery Test Results (SXOOF)

April 12, 2021 Stock Day Media Comments Off on St-Georges Releases Initial Cathode Material EV Battery Test Results (SXOOF)

NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission (GNBT)

April 12, 2021 Stock Day Media Comments Off on NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission (GNBT)

Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment (HALB)

April 12, 2021 Stock Day Media Comments Off on Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Covid-19 Inflammatory Cytokine Storm Treatment (HALB)

Copyright © 2021 Stock Day Media. All rights reserved.